For immune checkpoint inhibition, it has been shown that gene expression profiles from tumor tissue samples of different solid tumors who responded to anti-PD-1 therapy had higher expression of IFN-γ-related genes [22]. The gene discussed is IFNG; the disease is neoplasm.